Fatty Acids Lipidome and Oxidative Stress in Liver Transplantation
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to determine lipid metabolism in chronic liver disease in the attempt to find a useful biomarker of liver function and of prognostic value of graft function in those patients who undergo liver transplant. The present study enrolls subjects with liver cirrhosis (with different ethiology), including subjects eligible for a full-size liver transplantation, and healthy controls.
| Condition |
|---|
|
Liver Cirrhosis |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Time Perspective: Prospective |
| Official Title: | Fatty Acids Lipidome and Oxidative Stress Markers as Indicators of Liver Transplant Outcome |
- Post operative graft function after liver transplantation [ Time Frame: Change in graft function after 7 and 30 days after liver transplantation ] [ Designated as safety issue: No ]• Multiple lipid metabolism biomarkers (fatty acids, cholesterol and oxysterols) are evaluated in the plasma of liver cirrhosis patients before liver transplantation. A logistic regression model is used to evaluate which of these biomarkers is an independent predictor of graft function
- Early gene expression in the liver graft [ Time Frame: 30 days ] [ Designated as safety issue: No ]Assessment of lipid metabolism-, oxidative stress-, and ER stress-gene expression in graft tissue liver tissue specimens of patients undergoing organ transplantation and their impact on graft function. Lipid metabolism and ER gene expression (genes: LDL-R, HMGCR, CD81, SREBP2, NPC1L1, XBP-1, XBP2, ATF6, GRP78, GRP94, LXR, INSIG1, INSIG2) in liver graft specimens at transplantation before and after ischemia-reperfusion injury; downregulated and upregulated genes are related to early graft function.
Biospecimen Retention: Samples With DNA
Blood samples and liver biopsy specimens
| Estimated Enrollment: | 320 |
| Study Start Date: | July 2001 |
| Estimated Study Completion Date: | September 2011 |
| Estimated Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
Liver Cirrhosis
Patient with liver cirrhosis undergoing liver transplant
|
|
Liver donors
Subjects eligible for organ explant
|
| Healthy controls |
Detailed Description:
Liver has a central role in fatty acids metabolism that is impaired in chronic liver diseases. Polyunsaturated fatty acids are reportedly reduced in liver cirrhosis, which is considered a condition of essential fatty acids deficiency. However, there is a paucity of data concerning the level of the multitude of circulating fatty acids in liver cirrhosis. Oxidative stress is involved in the pathogenesis of chronic liver disease and fibrosis. Increased oxidative stress with impaired antioxidant status at the systemic level has been described in different chronic liver diseases and negatively influences graft function after liver transplantation (Poli G. 2000, Loguercio C 2003). 7-Ketocholesterol and 7beta-hydroxycholesterol, prototype molecules of free radical-mediated cholesterol oxidation, are very important oxysterols currently accepted as in vivo reliable markers of oxidative stress. High oxysterols plasma levels are associated with an alteration of normal plasma fatty acid pattern in cystic fibrosis (Iuliano 2009). The Model for End-Stage Liver Disease (MELD) score is a common score used routinely to stage liver function in patients with liver cirrhosis (Al Sibae 2010). After ischemia-reperfusion injury at liver transplantation oxidative stress, hepatic endoplasmic reticulum (ER) stress and cholesterol metabolism are interrelated key processes to preserve graft regeneration and function. A blood sample is obtained in each subject to measure MELD score at the first visit and at liver transplantation. Further blood samples are collected at days seven and 30 post transplantation. Blood samples are also obtained from healthy subjects. Liver biopsy samples are obtained from liver transplant donors. Oxidative stress and fatty acids lipidomics are measured to evaluate the actual plasma concentration in liver cirrhosis patients to be compared with healthy controls. Oxidative stress and fatty acids are also analyzed as a function of disease status, and for its influence on transplant outcomes. Lipid metabolism gene and endoplasmic stress reticulum gene expression are evaluated in liver biopsy specimen to study the influence on graft function.
Eligibility| Ages Eligible for Study: | 15 Years to 69 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
- 150 cirrhotic patients, including Hepatocellular Carcinoma (HCC), Hepatitis C Virus (HCV) positive patients
- 80 healthy controls
- 100 liver donors
Liver cirrhosis inclusion criteria:
- subjects with liver cirrhosis eligible for liver transplant, and one MELD score determination performed at least 3 months before liver transplantation
Liver cirrhosis exclusion criteria:
- liver transplant contraindication and re-transplantation
- current use of antioxidants and fatty acids supplements
Healthy controls are recruited recruited among the University personnel, after a review of their medical history.
Exclusion criteria for control participants included the use of drugs that affect fatty acids (systemic corticosteroids, isotretinoin, and ursodiol) and/or oxidative stress (antioxidants and hypolipemic drugs).
Contacts and Locations| Contact: Stefano Corradini, M.D., Ph.D. | +390649972086 | stefano.corradini@uniroma1.it |
| Italy | |
| Department of Clinical Medicine Division of Gastroenterology, Sapienza University of Rome | Recruiting |
| Rome, RM, Italy, 00161 | |
| Contact: Stefano Corradini, M.D., Ph.D. +39 06 4997 ext 2086 Stefano.Corradini@uniroma1.it | |
| Contact: Antonio Molinaro, M.D. +39 06 4997 ext 2086 antoniomolinaro83@libero.it | |
| Sub-Investigator: Antonio Molinaro, M.D. | |
| Liver Transplant Center Paride Stefanini, Sapienza University of Rome | Recruiting |
| Rome, RM, Italy, 00161 | |
| Contact: Massimo Rossi, M.D. +39 3346214536 massimo.rossi@uniroma1.it | |
| Laboratory of Vascular Medicine, Department of Medical Sciences and Biotechnology, Sapienza University of Rome | Recruiting |
| Latina, Italy, 04100 | |
| Contact: Luigi Iuliano, M.D. +39 0773 471046 luigi.iuliano@uniroma1.it | |
| Contact: Roberto Monticolo, Ph.D. +39 0773 471046 alessandropagnanelli@libero.it | |
| Principal Investigator: Luigi Iuliano, M.D. | |
| Sub-Investigator: Roberto Monticolo, M.D. | |
| Principal Investigator: | Stefano Corradini, M.D., Ph.D. | Sapienza University of Rome |
More Information
Publications:
| Responsible Party: | Corradini Stefano, Sapienza University of Rome, Department of Clinical Medicine |
| ClinicalTrials.gov Identifier: | NCT01389115 History of Changes |
| Other Study ID Numbers: | Iul_LC |
| Study First Received: | May 6, 2011 |
| Last Updated: | July 12, 2011 |
| Health Authority: | Italy: Ethics Committee |
Keywords provided by University of Roma La Sapienza:
|
liver cirrhosis oxidative stress liver transplant |
Additional relevant MeSH terms:
|
Liver Cirrhosis Fibrosis Liver Diseases Digestive System Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 21, 2013